Delivery Order SPE2DB22D2005-SPE2DB24FJPJ2

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,156.42 to Amerisourcebergen Drug Corp's Corporate Office division for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $2,807.64 to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a completion date of July 12, 2023. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00, which serves as the primary vehicle...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,392.48 contract is for the delivery of a pharmaceutical product, PROCTOFOAM-HC 1%-1% FOAM 10GM, to support military treatment programs and facilities. This delivery order is issued under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,163.87 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, to support military treatment programs and facilities. The delivery order has a completion date of February 7, 2024. Amerisourcebergen Drug Corp holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract, valued at $1,276.50, is a delivery order for PROCTOFOAM-HC 1%-1% FOAM 10GM. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,752.15 contract is for the provision of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a completion date of February 13, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The contract has a ceiling value of $2,026.00 and a firm fixed price pricing type. The contract is not a set-aside and has an ultimate completion date of May 9, 2024. Amerisourcebergen Drug Corp holds a significant...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. is a Delivery Order with a Firm Fixed Price valued at $1,761.96. The contract is for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical supply item, with a completion date of January 10, 2025. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical that runs through November...
This federal contract award is a delivery order valued at $2,280.40 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with a period of performance through June 4, 2025. This contract is not set-aside and represents an open competition award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564184900 - PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The $1,215.60 award has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is likely part of a larger indefinite delivery contract (IDC) the company holds with DLA...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJPJ2
    Delivery Order

The Defense Logistics Agency (DLA) awarded a delivery order contract worth $3,416.10 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain network to fulfill these government contracts, delivering essential medical commodities to support the DLA's mission of providing logistics and acquisition services to the U.S. Armed Forces and other government agencies.

Generated 9/27/24, 9:22 AM